Alcami
Wilmington, NC
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (9)
○ EMA GMP
○ MHRA GMP
Quick Facts: Alcami
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Wilmington, NC
- Modalities
- Sterile Fill-Finish, Drug Product (Injectable), Lyophilization, Small Molecule, Analytical Testing, Terminal Sterilization
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Alcami
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesSterile Fill-Finish, Drug Product (Injectable), Lyophilization, Small Molecule, Analytical Testing, Terminal Sterilization
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (6 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press9 articles
Broad modality coverage (6 modalities)
Recent News 9 articles
Alcami Acquires Tjoapack - Contract Pharma
Alcami to Acquire Contract Packaging Organization Tjoapack - PR Newswire
Alcami Completes Tjoapack Acquisition to Bolster Global Packaging Scale - CHEManager
Alcami Expands Drug Product Manufacturing Capacity to Meet Growing Demand - PR Newswire
Alcami Completes Acquisition of Tjoapack - PR Newswire
CDMO Alcami expands storage capacity at new manufacturing site - BioProcess International
Alcami Expands Out West With Latest Acquisition - WilmingtonBiz
Alcami Brings Third Sterile Fill-Finish Line Online, Expanding Clinical-to-Commercial Capacity - Pharmaceutical Commerce
Alcami invests in quality, packaging and storage upgrades at Tennessee site post-Tjoapack acquisition - Manufacturing Chemist
Frequently Asked Questions About Alcami
What is Alcami's CDMO Signal Score?
Alcami has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Alcami for a manufacturing program?
Use the free AI matchmaker to compare Alcami against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
Similar CDMOs
BioCina
Adelaide, Australia
Biologics (Microbial), Plasmid DNA, mRNA, LNP, Sterile Fill-Finish, Recombinant Proteins, Vaccines, Biosimilars, High Potency/Oncology Injectables, Blow-Fill-Seal
Roche / Genentech (Internal Manufacturing & CustomBiotech)
Basel, Switzerland
Biologics, mAb, Cell Therapy, Gene Therapy (AAV), Oligonucleotide, mRNA, Small Molecule
Pyramid Pharma Services (Pyramid Laboratories, Inc.)
Costa Mesa, CA
Biologics, Sterile Injectables / Aseptic Fill-Finish, Lyophilization, Peptides, Small Molecules, siRNA/Oligonucleotide Injectable, Formulation Development, Analytical & Stability Testing
PCI Pharma Services
Philadelphia, PA
Sterile fill-finish, Prefilled syringes, Cartridges, Vials, Lyophilization, ADC fill-finish, HPAPI, mRNA, Biologics, Oligonucleotides, Peptides
Bryllan LLC
Brighton, MI
Sterile Fill-Finish, Aseptic Powder & Liquid Filling, Biologics (Injectables), Potent/Cytotoxic Compounds, Hormones, mAbs/Antibodies, Live Viruses, Vaccines, Drug-Device Combination Products (Syringes, IV Bags, Cartridges)